Core Viewpoint - Ocugen (OCGN) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive trend in earnings estimates which is a significant factor influencing stock prices [1][2]. Group 1: Earnings Estimates and Stock Price Impact - The Zacks rating system is based on changes in earnings estimates, which are strongly correlated with near-term stock price movements [3]. - Institutional investors utilize earnings estimates to determine the fair value of stocks, leading to price movements based on their buying or selling actions [3]. Group 2: Ocugen's Earnings Outlook - For the fiscal year ending December 2025, Ocugen is expected to earn -$0.23 per share, unchanged from the previous year, but the Zacks Consensus Estimate has increased by 2.9% over the past three months [7]. - The upgrade to Zacks Rank 2 places Ocugen in the top 20% of Zacks-covered stocks, suggesting potential for higher stock movement in the near term [9]. Group 3: Zacks Rating System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a historical average annual return of +25% for Zacks Rank 1 stocks since 1988 [6]. - The system maintains a balanced distribution of ratings, ensuring that only the top 20% of stocks receive favorable ratings, which enhances the reliability of the ratings [8].